Applied Genetic Technologies Corporation
AGTC · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $46 | $105 | $38 | $27 |
| Short-Term Investments | $0 | $2 | $42 | $55 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $5 | $45 | $58 |
| Total Curr. Assets | $50 | $110 | $83 | $84 |
| Property Plant & Equip (Net) | $8 | $8 | $8 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $8 | $8 | $8 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $17 | $17 | $17 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $67 | $127 | $100 | $92 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $1 | $1 |
| Short-Term Debt | $11 | $3 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $15 | $11 | $8 |
| Total Curr. Liab. | $25 | $20 | $13 | $9 |
| LT Debt | $12 | $21 | $10 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $7 | $4 |
| Total NC Liab. | $12 | $21 | $16 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $37 | $41 | $29 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$308 | -$239 | -$181 | -$136 |
| AOCI | $0 | $0 | -$5 | -$4 |
| Other Equity | $338 | $325 | $252 | $214 |
| Total Equity | $29 | $86 | $71 | $79 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $67 | $127 | $100 | $92 |
| Net Debt | -$24 | -$81 | -$28 | -$27 |